Table 1.
Sample characteristics
| MCP (n=109) | SP (n=108) | EUC (n=104) | F / χ2 | p | |
|---|---|---|---|---|---|
|
| |||||
| Gender | |||||
| Male | 28 (25.7%) | 37 (34.3%) | 26 (25.0%) | χ2 = 2.81 | p = .25 |
| Female | 81 (74.3%) | 71 (65.7%) | 78 (75.0%) | d.f.=2 | |
|
| |||||
| Age (Mean/SD) | 58.1 (10.2) | 58.8 (12.0) | 57.1 (10.9) | F = 0.56 | p = .57 |
|
| |||||
| Years of Education (Mean/SD) | 16.7 (2.7) | 16.4 (2.5) | 16.5 (2.5) | F = 0.51 | p = .60 |
|
| |||||
| Race/Ethnicity | |||||
| Caucasian/Non-Hispanic | 83 (76.1%) | 82 (75.9%) | 78 (75.0%) | χ2 = 6.39 | p = .38 |
| African-American | 14 (12.8%) | 10 (9.3%) | 7 (6.7%) | d.f.=6 | |
| Hispanic | 8 (7.3%) | 8 (7.4%) | 14 (13.5%) | ||
| Other | 4 (3.7%) | 8 (7.4%) | 5 (4.8%) | ||
|
| |||||
| Religion | |||||
| Catholic | 32 (29.6%) | 36 (33.3%) | 35 (33.7%) | χ2 = 2.96 | p = .94 |
| Other Christian | 22(20.4%) | 23 (21.3%) | 18 (17.3%) | d.f.=8 | |
| Jewish | 28 (25.9%) | 28 (25.9%) | 26 (25.0%) | ||
| Other | 9 (8.3%) | 6 (5.6%) | 5 (4.8%) | ||
| None | 17 (15.7%) | 15 (13.9%) | 20 (19.2%) | ||
|
| |||||
| Primary Cancer Diagnosis | |||||
| Breast | 13 (14.1%) | 9 (10.3%) | 12 (16.2%) | χ2=10.83 | p = .37 |
| Colon/Rectal | 14 (15.2%) | 8 (9.2%) | 11 (14.9%) | d.f.=10 | |
| Lung | 11 (12.0%) | 21 (24.1%) | 11 (14.9%) | ||
| Ovarian | 17 (18.5%) | 10 (11.5%) | 11 (14.9%) | ||
| Pancreas | 18 (19.6%) | 18 (20.7%) | 9 (12.2%) | ||
| Other | 19 (20.7%) | 21 (24.1%) | 10 (27.0%) | ||
|
| |||||
| Karnofsky Performance score (Mean/SD) | 80.9 (8.2) | 80.5 (8.5) | 80.3 (7.9) | F = 0.17 | p = .85 |
|
| |||||
| Distress Thermometer (Mean/SD) | 6.3 (1.7) | 6.2 (1.8) | 6.2 (1.8) | F = 0.24 | p = .79 |